Saamya Biotech India has informed that a meeting of the Board of Directors of the Company will be held on November 14, 2014, inter alia, to consider the un-audited financial results for the quarter ended September 30, 2014, regarding Trading approval for 17,90,000 Equity shares allotted pursuant to conversion of equity warrants issued on preferential basis.
The above information is a part of company’s filings submitted to BSE